ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,237.72
-0.42%
Dow Jones
39,150.33
0.04%
Gold vs US Dollar
2,320.79
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,368.71
0.19%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kite Pharma, Inc. (KITE)

  7. Kite Pharma, Inc. (KITE) News

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KITE
DateTimeSourceHeadlineSymbolCompany
13/10/201722:05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KITEKite Pharma, Inc.
05/10/201720:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201722:12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
03/10/201722:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
03/10/201722:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
03/10/201721:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
03/10/201721:56Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KITEKite Pharma, Inc.
03/10/201721:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
03/10/201714:03Edgar (US Regulatory)(25-NSE)NASDAQ:KITEKite Pharma, Inc.
03/10/201713:46Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201713:45Business WireGilead Sciences Completes Acquisition of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
03/10/201713:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201713:00Business WireGilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
26/09/201713:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
26/09/201713:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
26/09/201713:30Business WireGilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:KITEKite Pharma, Inc.
25/09/201722:17Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
25/09/201722:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
25/09/201721:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
22/09/201721:18Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
18/09/201722:29Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
15/09/201721:52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
08/09/201722:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
08/09/201722:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
08/09/201718:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
07/09/201721:12Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
05/09/201721:13Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:KITEKite Pharma, Inc.
05/09/201721:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
05/09/201717:24Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:KITEKite Pharma, Inc.
01/09/201722:28Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:KITEKite Pharma, Inc.
 Showing the most relevant articles for your search:NASDAQ:KITE

Your Recent History

USOTC
KOMBY
Komercni Banka AS (PK)
BOV
PLPL3F
Plano & Plano Desenvolvi... ON
TG
ES50
BlackRock Asset Manageme...
BOV
RRRP3F
3R Petroleum Oleo E Gas ... ON
TG
RL4V
Cooperative Centrale Rai...
LSE
BO62
Barclays 27
USOTC
BKRHF
Bunka Shutter (PK)
NASDAQI
OB30LFL
Optimal Blue 30Yr Conf F...
COIN
RPXGBP
Red Pulse
BOV
EVEN3M
EVEN ON
LSE
BX90
Bae Sys 34 S
NASDAQ
TANH
Tantech
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved